Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.
Geraldes R, Juryńczyk M, Dos Passos G, Prichler A, Chung K, Hagens M, Ruggieri S, Huerga E, Sastre-Garriga J, Enzinger C, Chard DT, Barkhof F, Gasperini C, Rovira A, DeLuca GC, Palace J; MAGNIMS study group. Geraldes R, et al. Among authors: jurynczyk m. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):388-391. doi: 10.1136/jnnp-2019-322369. Epub 2020 Feb 7. J Neurol Neurosurg Psychiatry. 2020. PMID: 32034114
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.
Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Juryńczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A. Waters P, et al. Among authors: jurynczyk m. Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89. doi: 10.1212/NXI.0000000000000089. eCollection 2015 Jun. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25821844 Free PMC article.
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. Juryńczyk M, et al. J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3. J Neurol. 2016. PMID: 26530512 Free PMC article.
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J. Jurynczyk M, et al. Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. Brain. 2017. PMID: 29136091
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Jurynczyk M, Probert F, Yeo T, Tackley G, Claridge TDW, Cavey A, Woodhall MR, Arora S, Winkler T, Schiffer E, Vincent A, DeLuca G, Sibson NR, Isabel Leite M, Waters P, Anthony DC, Palace J. Jurynczyk M, et al. Acta Neuropathol Commun. 2017 Dec 6;5(1):95. doi: 10.1186/s40478-017-0495-8. Acta Neuropathol Commun. 2017. PMID: 29208041 Free PMC article.
32 results